What Is BPC-157? Research, Rules and Safety | telos rx
Runner mid stride on an open road in bright daylight, showing an active lifestyle
← Back to blog
BPC-157

What Is BPC-157? Research, Rules and Safety

By telos rx Editorial Team

What is BPC-157? It is a lab-made peptide of 15 amino acids, based on a protein found in stomach fluid. Most research is in animals, human data is very limited, and it is not FDA-approved. See how telos rx offers it.

Written by the telos rx Editorial Team. Last reviewed: 17 November 2026.

BPC-157 shows up everywhere online, often with big promises attached. The research behind it is far thinner than the hype suggests. Knowing what is known, and what is not, helps you make a calmer decision.

This guide explains what BPC-157 is and what animal and human studies have looked at. It also covers where it stands with regulators and which safety questions remain open.

BPC-157 in brief

Question Short answer
What is it? A synthetic peptide made of 15 amino acids
Where does the name come from? "Body Protection Compound", a protein fragment first described from human gastric juice
What is its FDA status? Compounded BPC-157 is not FDA-approved
Where is most research? Animal and cell studies
How much human research exists? Very little: small, uncontrolled studies
Can athletes use it? It is prohibited in tested sport
How is it available in the US? By prescription from a licensed provider, compounded by a state-licensed pharmacy

What BPC-157 actually is

Peptides are short chains of amino acids, the building blocks of proteins. BPC-157 is a chain of 15. Scientists call that a pentadecapeptide.

It is described as a fragment of a larger protein found in human gastric juice. The version used in research and compounding is made in a lab. It is not extracted from people.

BPC-157 is not a vitamin, a supplement or a hormone. It is an experimental compound that has never completed the clinical trials needed for FDA approval.

Why people are interested in it

Interest comes mainly from animal research. Over several decades, labs have tested BPC-157 in rodent models of tendon, muscle, ligament, bone and gut injury.

Many of those studies reported encouraging findings in animals. That is why the compound became popular in fitness and wellness circles.

The catch is that animal results often do not carry over to people. Many compounds that look promising in rats fail in human trials. With BPC-157, those human trials largely have not been done.

What animal and cell studies have looked at

Animal and cell evidence: researchers have studied BPC-157 in injury models in rats and mice, and in cells grown in the lab. Common areas include:

  • Tendon and ligament injury models.
  • Muscle and bone injury models.
  • Models of gut lining damage and inflammation.
  • Blood vessel formation and blood flow in tissue.

Much of this work comes from a small number of research groups. Independent replication is limited. Doses, routes and study designs vary widely, which makes the findings hard to compare.

Human evidence for these areas: largely absent. There are no large, controlled human trials testing BPC-157 for any of these uses.

How BPC-157 is thought to work

Animal and cell evidence: lab studies suggest BPC-157 may interact with several signaling systems. These include the nitric oxide pathway, growth factor signaling and the formation of new blood vessels.

These are hypotheses drawn from preclinical work. They help explain why researchers keep studying the compound.

Human evidence: no human study has confirmed how BPC-157 works in people. Mechanisms seen in a dish or a rodent may not happen the same way in the human body.

What human studies show

The human evidence is small. A 2026 systematic review of human BPC-157 studies searched the medical literature up to June 2026. It found only three studies, with 30 people in total.

  • A retrospective study of BPC-157 injected into the knee for knee pain, with 16 people.
  • A retrospective pilot study of BPC-157 given into the bladder for interstitial cystitis, with 12 people.
  • A small prospective pilot study of intravenous BPC-157 safety, with 2 people.

The studies reported symptom changes and no treatment-related adverse events. But the review judged all three to be of poor methodological quality. It rated the overall certainty of evidence as very low.

The authors concluded that BPC-157 should not be used clinically outside ethically reviewed, regulated, high-quality clinical trials. That is a sobering summary, and it is worth reading before any decision.

Considering BPC-157 through a licensed provider?

telos rx offers compounded BPC-157 as a single-ingredient product after an online clinical review. It is not FDA-approved, and any prescription is subject to medical approval by a licensed provider.

Learn about BPC-157

Safety: what is known and unknown

Because human research is so limited, the honest answer on safety is that much is unknown.

  • Short-term human data: the few small studies did not report treatment-related adverse events. Thirty people is far too few to detect uncommon problems.
  • Long-term human data: absent. No study has followed people using BPC-157 for long periods.
  • Theoretical questions: BPC-157 appears to affect blood vessel growth in animal studies. Researchers have asked whether that could matter for people with cancer or a history of cancer. There is no human data to answer this.
  • Pregnancy and breastfeeding: no human safety data.
  • Interactions: not studied in people. Tell your provider about every medicine and supplement you take.

If you have bloodwork or health checks in progress, mention them. Our guide to peptide therapy blood work explains which labs providers sometimes request and why. Labs cannot prove a peptide is safe, but they can flag issues worth reviewing first.

Product quality is a separate risk. Peptides sold online as "research use only" may not contain what the label says. They are not meant for human use.

Seek urgent care for signs of a serious allergic reaction, such as swelling of the face or throat, or trouble breathing. Contact your clinician about any new or worrying symptom.

Who should be especially cautious

Some groups have even less information to go on. Talk this through carefully with a clinician if any of these apply to you.

  • People with active cancer or a past history of cancer.
  • People who are pregnant, trying to conceive or breastfeeding.
  • People under 18.
  • People with serious heart, kidney or liver conditions.
  • People taking several prescription medicines.
  • Athletes in tested sport.

A licensed provider may decide BPC-157 is not appropriate for you. That is a normal and responsible outcome of a clinical review.

BPC-157 and FDA status

BPC-157 has never completed the clinical trials needed for FDA approval. Compounded BPC-157 is not FDA-approved.

Compounded medicines are prepared by state-licensed pharmacies for individual patients with a prescription. The FDA does not review them for safety, effectiveness or quality before they reach patients.

The HHS enforcement discretion policy

On 30 October 2026, HHS published an interim enforcement discretion policy. It appeared in the Federal Register, document 2026-22192. It covers compounding with six peptides, including BPC-157.

In short, HHS said it does not intend to take enforcement action against state-licensed pharmacies and licensed physicians compounding these peptides, under strict conditions. The policy stays in place until each peptide is addressed in a final rule.

  • Single ingredient: each product must contain one active ingredient. Blends are excluded.
  • Prescription: a valid patient-specific prescription is required.
  • Sourcing: ingredients must come from FDA-registered suppliers.
  • Routes for BPC-157: subcutaneous, intramuscular, oral and topical.

This is not FDA approval. It is not a final listing, and HHS says it may revisit the policy. The notice states the policy is not binding on HHS or the public. Rules can change, so check the latest version. This summary reflects the policy as checked on 17 November 2026.

Our full explainer on the HHS peptide policy covers every condition in detail.

Common myths about BPC-157

  • "It is a natural body chemical." It is based on a fragment of a stomach protein, but the product is made in a lab. Your body does not make BPC-157 as a standalone compound.
  • "Studies show it works." Most studies are in animals. The human studies are tiny, uncontrolled and rated very low certainty.
  • "It has no side effects." There is not enough human data to say that. Absence of evidence is not evidence of safety.
  • "The HHS policy means it has FDA approval." It does not. The policy is about enforcement, it has conditions, and it can be revised.
  • "Research-use vials are the same thing." They are not made or labeled for human use, and quality can vary widely.

How to read BPC-157 claims online

Many websites that discuss BPC-157 also sell it. That does not make every claim wrong, but it is a reason to check sources.

Ask three questions about any claim. Was the study in people or animals? How many people took part? Was there a control group? If a page cannot answer those, read the claim as a hypothesis rather than a fact.

Also watch for before-and-after stories and recovery timelines. Those are anecdotes. They cannot tell you what BPC-157 would do for you.

BPC-157 and tested sport

If you compete in tested sport, BPC-157 is off limits. USADA explains that it is prohibited under category S0 of the WADA Prohibited List. S0 covers substances without regulatory approval for human therapeutic use.

The HHS policy does not change anti-doping rules. Athletes should always check the current WADA Prohibited List before using any substance.

BPC-157 and TB-500

BPC-157 is often discussed alongside TB-500, another research peptide. Online sellers sometimes offer both in one blended vial. Blends fall outside the HHS policy.

At telos rx, BPC-157 and TB-500 are available only as two separate single-ingredient vials, never one blend. TB-500 is not sold on its own. See the BPC-157 and TB-500 page for details.

The human evidence for TB-500 is also very limited. Combining two compounds with thin evidence does not make the evidence stronger.

How BPC-157 compares with standard care

For injuries and gut problems, standard care has far more evidence behind it. That includes medical evaluation, imaging when needed, physical therapy, graded exercise, sleep and nutrition.

BPC-157 is not a substitute for any of these. If you have pain, an injury or ongoing gut symptoms, get a medical evaluation first. Some causes need specific care that a peptide cannot replace.

Our review of recovery peptide research compares the evidence across several peptides and standard approaches.

Questions to ask before considering BPC-157

  • What does the human evidence actually show for my situation?
  • What are the known and unknown risks for me?
  • Have I had a proper evaluation of the underlying problem?
  • Which state-licensed pharmacy prepares the product?
  • Is it a single-ingredient product with a clear label?
  • Do I compete in tested sport?
  • What does it cost, and is that worth it given the thin evidence?

Our guides to peptide therapy eligibility and peptide therapy cost cover what providers usually check and what you may pay.

How telos rx offers BPC-157

telos rx is an online-first, asynchronous telehealth service. You complete a private intake online. A licensed provider reviews it, and you message your care team rather than booking video calls.

If prescribed, compounded BPC-157 is prepared by a state-licensed pharmacy as a single-ingredient product. The telos rx BPC-157 page lists it as low as $116 per month, as of 17 November 2026. Your provider determines the dose and form.

Every prescription is subject to medical approval by a licensed provider. Approval is not guaranteed, and a provider may decide BPC-157 is not right for you.

Start a private peptide evaluation

Answer health questions online, on your schedule. A licensed provider reviews them, and any prescription is subject to medical approval by a licensed provider.

Check my eligibility

Frequently Asked Questions

What is BPC-157 made of?

BPC-157 is a synthetic peptide made of 15 amino acids. It is described as a fragment of a protein found in human gastric juice, which is where the name Body Protection Compound comes from. The versions used in research and compounding are made in a lab, not extracted from people.

Does BPC-157 have FDA approval?

No. BPC-157 has never completed the clinical trials needed for FDA approval, and compounded BPC-157 is not FDA-approved. The HHS interim policy published on 30 October 2026 is an enforcement decision, not approval. It applies only under strict conditions and can be revised at any time.

What does the human research on BPC-157 show?

Very little. A 2026 systematic review found only three human studies with 30 people in total. All were small and uncontrolled, and the review rated the certainty of evidence as very low. Most BPC-157 research is in animals and cells, and those results may not apply to people.

Is BPC-157 safe?

Nobody can say with confidence. The few small human studies did not report treatment-related adverse events, but they were far too small to detect uncommon problems. Long-term human safety data does not exist. Products sold for research use only may not contain what their labels claim, which adds another risk.

Can athletes use BPC-157?

No, not in tested sport. USADA explains that BPC-157 is prohibited under category S0 of the WADA Prohibited List. The HHS compounding policy does not change anti-doping rules. Athletes should check the current WADA Prohibited List, or ask their anti-doping organization, before using any substance.

How do people get BPC-157 through a licensed provider?

In the US, through a prescription from a licensed provider, compounded by a state-licensed pharmacy as a single-ingredient product. telos rx offers compounded BPC-157 after an online clinical review. Your provider determines the dose and form, and every prescription is subject to medical approval by a licensed provider.

telos rx is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Approval is subject to evaluation by a licensed provider; approval is not guaranteed. Individual results vary. telos rx operates as an online-first, asynchronous telehealth service.

Ready to see if it fits? Start your private evaluation with telos rx.

Related research

Compounded medications are compounded, not FDA-approved. Prescriptions are never automatic or guaranteed. TelosRX operates under LegitScript-certified telehealth standards as an online-first, asynchronous telehealth service.

Read more from TelosRX